| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.87T | 5.02T | 4.83T | 3.83T | 3.12T | 2.88T |
| Gross Profit | 720.10B | 1.08T | 1.04T | 801.52B | 687.70B | 613.64B |
| EBITDA | 145.09B | 283.42B | 419.51B | 284.40B | 194.51B | 98.58B |
| Net Income | 9.29B | 114.08B | 207.70B | 142.81B | 81.56B | -31.65B |
Balance Sheet | ||||||
| Total Assets | 4.22T | 4.09T | 3.79T | 3.26T | 2.97T | 2.92T |
| Cash, Cash Equivalents and Short-Term Investments | 1.14T | 1.21T | 922.56B | 717.10B | 740.39B | 739.00B |
| Total Debt | 898.88B | 723.00B | 575.79B | 627.13B | 680.81B | 755.93B |
| Total Liabilities | 2.38T | 2.28T | 2.03T | 1.80T | 1.65T | 1.72T |
| Stockholders Equity | 1.81T | 1.79T | 1.74T | 1.44T | 1.30T | 1.18T |
Cash Flow | ||||||
| Free Cash Flow | -98.05B | 177.36B | 303.65B | 38.30B | 49.80B | 34.02B |
| Operating Cash Flow | -5.48B | 305.63B | 418.89B | 137.42B | 189.16B | 120.06B |
| Investing Cash Flow | -149.91B | -199.96B | -179.89B | -99.43B | -136.24B | -78.86B |
| Financing Cash Flow | 163.49B | 90.07B | -84.70B | -89.86B | -86.41B | 99.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $307.78B | 8.55 | 10.34% | 2.57% | 7.28% | 12.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $37.02B | 9.64 | 4.11% | 4.19% | 0.32% | -25.51% | |
57 Neutral | $71.05B | 27.72 | 4.34% | 0.69% | -1.29% | -49.96% | |
56 Neutral | $51.11B | -6.38 | -20.26% | 5.64% | 3.75% | 33.37% | |
53 Neutral | $4.94B | 6.12 | 1.72% | 4.59% | -0.25% | -77.23% | |
45 Neutral | $10.54B | -9.00 | -296.44% | ― | 14.94% | 2.53% |